BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9158030)

  • 1. Split tolerance induced by immunotoxin in a rhesus kidney allograft model.
    Fechner JH; Vargo DJ; Geissler EK; Graeb C; Wang J; Hanaway MJ; Watkins DI; Piekarczyk M; Neville DM; Knechtle SJ
    Transplantation; 1997 May; 63(9):1339-45. PubMed ID: 9158030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys.
    Jonker M; Ringers J; Ossevoort MA; Slingerland W; van den Hout Y; Haanstra K; Wubben J; Kuhn E; Friend P; Calne R
    Transplantation; 2002 Mar; 73(6):874-80. PubMed ID: 11923686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts.
    Knechtle SJ; Vargo D; Fechner J; Zhai Y; Wang J; Hanaway MJ; Scharff J; Hu H; Knapp L; Watkins D; Neville DM
    Transplantation; 1997 Jan; 63(1):1-6. PubMed ID: 9000652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.
    Armstrong N; Buckley P; Oberley T; Fechner J; Dong Y; Hong X; Kirk A; Neville D; Knechtle S
    Transplantation; 1998 Jul; 66(1):5-13. PubMed ID: 9679815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
    Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
    Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primate renal transplants using immunotoxin.
    Knechtle SJ; Fechner JH; Dong Y; Stavrou S; Neville DM; Oberley T; Buckley P; Armstrong N; Rusterholz K; Hong X; Tsuchida M; Hamawy MM
    Surgery; 1998 Aug; 124(2):438-46; discussion 446-7. PubMed ID: 9706169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model.
    Fechner JH; Vargo DJ; Geissler EK; Wang J; Neville DM; Knechtle SJ
    Transplant Proc; 1997; 29(1-2):1158. PubMed ID: 9123249
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with immunotoxin.
    Knechtle SJ
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients.
    Hadley GA; Anderson CB; Mohanakumar T
    Transplantation; 1992 Aug; 54(2):333-7. PubMed ID: 1386694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
    Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism.
    Thomas JM; Carver FM; Kasten-Jolly J; Haisch CE; Rebellato LM; Gross U; Vore SJ; Thomas FT
    Transplantation; 1994 Jan; 57(1):101-15. PubMed ID: 8291095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity.
    de Haan A; van den Berg AP; Hepkema BG; van Dijk E; Haagsma EB; The TH; Slooff MJ; Lems SP; de Leij LF; Prop J
    Transplantation; 1998 Aug; 66(4):516-22. PubMed ID: 9734497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
    Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
    Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of T lymphocytes for adhesion and cytokine expression by toxin-conjugated anti-CD3 monoclonal antibodies.
    Hamawy MM; Tsuchida M; Manthei ER; Dong Y; Fechner JE; Knechtle JS
    Transplantation; 1999 Sep; 68(5):693-8. PubMed ID: 10507490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts.
    Thomas JM; Neville DM; Contreras JL; Eckhoff DE; Meng G; Lobashevsky AL; Wang PX; Huang ZQ; Verbanac KM; Haisch CE; Thomas FT
    Transplantation; 1997 Jul; 64(1):124-35. PubMed ID: 9233712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
    Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
    Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.
    Contreras JL; Wang PX; Eckhoff DE; Lobashevsky AL; Asiedu C; Frenette L; Robbin ML; Hubbard WJ; Cartner S; Nadler S; Cook WJ; Sharff J; Shiloach J; Thomas FT; Neville DM; Thomas JM
    Transplantation; 1998 May; 65(9):1159-69. PubMed ID: 9603161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9.
    Neville DM; Scharff J; Hu HZ; Rigaut K; Shiloach J; Slingerland W; Jonker M
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):85-92. PubMed ID: 8732691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy.
    Thomas JM; Eckhoff DE; Contreras JL; Lobashevsky AL; Hubbard WJ; Moore JK; Cook WJ; Thomas FT; Neville DM
    Transplantation; 2000 Jun; 69(12):2497-503. PubMed ID: 10910269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.